Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial

Journal of Gastroenterology

Volumn 50, Issue 12, 2015, Pages 1197-1205

  Beppu, Toru ^a,b   Nitta, Hidetoshi ^a   Hayashi, Hiromitsu ^a   Imai, Katsunori ^a   Okabe, Hirohisa ^a   Nakagawa, Shigeki ^a   Hashimoto, Daisuke ^a   Chikamoto, Akira ^a   Ishiko, Takatoshi ^a   Yoshida, Morikatsu ^a   Yamashita, Yasuyuki ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Branched chain amino acids; Functional liver regeneration; Liver uptake value; Major hepatectomy; Portal vein embolization

Indexed keywords

ALBUMIN; BRANCHED CHAIN AMINO ACID; HUMAN SERUM ALBUMIN TC 99M; ISOLEUCINE; LEUCINE; VALINE; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG UPTAKE; FEMALE; HEART; HEMIHEPATECTOMY; HUMAN; IMAGE PROCESSOR; LIVER; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; LIVER SCINTISCANNING; LIVER WEIGHT; MALE; PORTAL VEIN EMBOLIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; ARTIFICIAL EMBOLIZATION; DIETARY SUPPLEMENT; DRUG EFFECTS; LIVER NEOPLASMS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PORTAL VEIN; PROCEDURES; SCINTISCANNING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMINO ACIDS, BRANCHED-CHAIN; DIETARY SUPPLEMENTS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; ORGAN SIZE; PERIOPERATIVE CARE; PORTAL VEIN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84949531075     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1067-y     Document Type: Article

References (42)

1. Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665–72.
2. Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237:208–17.
3. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.
4. van den Esschert JW, de Graaf W, van Lienden KP, et al. Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization: recovery after PVE and liver resection. J Gastrointest Surg. 2009;13:1464–9.
5. Chen MF, Hwang TL, Hung CF. Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg. 1991;213:227–9.
6. Okabe H, Beppu T, Nakagawa S, et al. Percentage of future liver remnant volume before portal vein embolization influences the degree of liver regeneration after hepatectomy. J Gastrointest Surg. 2013;17:1447–51.
7. 99mTc-GSA scintigraphy with SPECT for assessment of hepatic function and functional volume during liver regeneration in a rat model of partial hepatectomy. J Nucl Med. 2008;49:122–8.
8. Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;25:540–8.
9. Lesurtel M, Graf R, Aleil B, et al. Platelet derived serotonin mediates liver regeneration. Science. 2006;312:104–7.
10. Olthoff KM. Hepatic regeneration in living donor liver transplantation. Liver Transplant. 2003;9(10 Suppl 2):S35–41.
11. 99mTc-galactosyl human serum albumin scintigraphy SPECT–computed tomography fusion system. J Gastroenterol. 2011;46:938–43.
12. Yoshida M, Shiraishi S, Sakaguchi F, et al. Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve? Jpn J Radiol. 2012;30:255–62.
13. 99mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease. Jpn J Radiol. 2012;30:435–41.
14. de Graaf W, van Lienden KP, van den Esschert JW, et al. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg. 2011;98:825–34.
15. Kwon AH, Matsui Y, Ha-Kawa SK, et al. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol. 2001;96:541–6.
16. Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. World J Gastroenterol. 2013;19:7620–9.
17. Muto Y, Sato S, Watanabe A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res. 2006;35:204–14.
18. Ichikawa K, Okabayashi T, Maeda H, et al. Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study. Surg Today. 2013;43:720–6.
19. Kim SJ, Kim DG, Lee MD. Effects of branched-chain amino acid infusions on liver regeneration and plasma amino acid patterns in partially hepatectomized rats. Hepatogastroenterology. 2011;58:1280–5.
20. Tomiya T, Omata M, Fujiwara K. Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor. Biochem Biophys Res Commun. 2004;313:411–6.
21. Meng WC, Leung KL, Ho RL, et al. Prospective randomized control study on the effect of branched chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg. 1999;69:811–5.
22. Okabayashi T, Iyoki M, Sugimoto T, et al. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids. 2011;40:1213–20.
23. Katsuragawa H, Yamamoto M. Hepatectomy and elemental nutrition. Jpn J Med Pharm Sci. 2007;57:121–5 (in Japanese).
24. Beppu T, Iwatsuki M, Okabe H, et al. A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol. J Gastroenterol. 2009;45:211–7.
25. Okabe H, Beppu T, Chikamoto A, et al. Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution. Int J Clin Oncol. 2014;19:614–21.
26. Beppu T, Ishiko T, Chikamoto A, et al. Liver hanging maneuver decrease blood loss and operative time in a right-side hepatectomy. Hepatogastroenterology. 2012;59:542–5.
27. Mitsumori A, Nagaya I, Kimoto S, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377–82.
28. 99mTc-GSA SPECT/CT fused imaging. Ann Nucl Med. 2014;28:780–8.
29. Okabe H, Beppu T, Ishiko T, et al. Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival. J Surg Oncol. 2011;104:641–6.
30. Hayashi H, Beppu T, Okabe H, et al. Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy. Surgery. 2015;157:20–6.
31. Mizuguchi T, Kawamoto M, Meguro M, et al. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2011;15:1433–9.
32. Aoyama K, Tsuchiya M, Mori K, et al. Effect of a late evening snack on outpatients with liver cirrhosis. Hepatol Res. 2007;37:608–14.
33. Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012;27:430–41.
34. Holecek M, Simek J, Kruf M, et al. Effect of branched chain amino acids on liver regeneration after partial hepatectomy. Physiol Bohemoslov. 1985;34:359–66.
35. Yoshida R, Yagi T, Sadamori H, et al. Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation. J Hepatobiliary Pancreat Sci. 2012;19:438–48.
36. Okabayashi T, Nishimori I, Yamashita K, et al. Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas. Amino Acids. 2010;38:901–7.
37. Yoshiji H, Noguchi R, Kitada M, et al. Branched-chain amino acid suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats. J Gastroenterol. 2009;44:483–91.
38. Cho JY, Suh KS, Kwon CH, et al. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery. 2006;139:508–15.
39. Arakawa M, Masaki T, Nishimura J, et al. The effects of branched-chain amino acid granules on the accumulation of tissue triglycerides and uncoupling proteins in diet-induced obese mice. Endocr J. 2011;58:161–70.
40. Fujioka H, Kawashita Y, Kamohara Y, et al. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol. 1999;28:329–33.
41. Kawamura H, Kamiyama T, Nakagawa T, et al. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol. 2008;23:1235–41.
42. Ninomiya S, Shimizu M, Imai K, et al. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells. Cancer Prev Res. 2011;4:2092–100.